News Contact Location Quality Technology Custom Manufacturing Products

OUR APIs MEET YOUR REQUIREMENTS BY 100%

Each year, approximately 200 tons of Active Pharmaceutical Ingredients, from 100 grams to 80 tons, leave our company and are delivered to customers in 65 countries on 5 continents.

All synthesis steps are monitored by an intensive in-process-control in order to evoid undesired side products and impurities. Thereby, we can control the synthesis process in all steps.

Our wide range of product specifications covers the quality requirements of various markets and pharmaceutical formulations. Upon request, Arevipharma provides the products in customized polymorphic forms, crystals and particle size distributions. For the adoption of the particle sizes, we use our extensive expertise in sieving, milling and micronising.

Here you may request our Product Information (currently available particle size distributions, packaging sizes, …) and the Material Safety Data Sheets as a PDF file. Please fill in the following form.



Here you may request our current Material Safety Data Sheets as a PDF file. Please fill in the following form.

Name



E-Mail



Product




Download our Productlist

Narcotic APIs

Controlled substances in Germany

Name CAS Nr. Quality Documents
Amfepramon Hydrochloride
Diethylpropione Hydrochloride **
Appetite Depressant
134-80-5 USP US-DMF, ASMF
Buprenorphine
Analgesic
52485-79-7 PhEur, USP CEP, US-DMF, ASMF
Buprenorphine Hydrochloride
Analgesic
53152-21-9 PhEur,USP CEP, US-DMF, ASMF
Fentanyl
Analgesic
437-38-7 PhEur CEP, ASMF
Fentanyl Citrate
Analgesic
990-73-8 PhEur, USP CEP, ASMF
Hydromorphone Hydrochloride
Analgesic
71-68-1 PhEur, USP CEP, ASMF
Oxycodone Hydrochloride
Analgesic
124-90-3 PhEur, USP CEP, ASMF
Remifentanil Hydrochloride
Analgesic
132539-07-2 IHS ASMF
Tilidine Hydrochloride Hemihydrate
Analgesic
27107-79-6 PhEur CEP, ASMF


Regular APIs

Name CAS Nr. Quality Documents
Amiodarone Hydrochloride
Antiarrhythmic
19774-82-4 PhEur CEP, ASMF
Bisoprolol Fumarate
Antihypertonic, beta block
104344-23-2 PhEur, USP CEP, US-DMF, ASMF
Carbamazepine
Antiepileptic, Anticonvulsant
298-46-4 PhEur, USP CEP, ASMF
Carvedilol
Antihypertonic, beta1-ad
72956-09-3 PhEur, USP CEP, ASMF
Cetirizine Dihydrochloride
Antihistaminic
83881-52-1 PhEur, USP CEP, ASMF
Clozapine
Neuroleptic
5786-21-0 PhEur CEP, US-DMF, J-DMF, ASMF
Dimethylfumarate
Psoriasis, Multiple Sclerosis
624-49-7 IHS US-DMF, ASMF
Ebastine
Antihistaminic
90729-43-4 PhEur CEP, ASMF
Flutamide
Antineoplastic
13311-84-7 PhEur, USP CEP, US-DMF, ASMF
Hydrochlorothiazide
Diuretic
58-93-5 PhEur CEP, ASMF
Ketamine Hydrochloride
Analgesic
1867-66-9 PhEur, USP CEP, US-DMF, ASMF
Memantine Hydrochloride
Antispasmodic, Antiparkinson, Muscle Relaxant
41100-52-1 IHS ASMF
Metaxalone
Skeletal Muscle Relaxant
1665-48-1 USP US-DMF, ASMF
Moxonidine
Antihypertensive
75438-57-2 PhEur CEP, ASMF
Mycophenolate Mofetil
Immunosuppressive
116680-01-4 PhEur, USP CEP, ASMF
Phenprocoumon
Anticoagulant
435-97-2 DAC ASMF
Pyridostigmine Bromide
Parasympathomimetic
101-26-8 PhEur, USP CEP, US-DMF, ASMF
Sotalol Hydrochloride
Antihypertonic, Antiarrhythmic
959-24-0 PhEur, USP CEP, US-DMF, ASMF
Sultiame
Antiepileptic, Anticonvulsant
61-56-3 IHS ASMF
Torasemide
Diuretic
56211-40-6 PhEur, USP CEP, US-DMF, ASMF, J-DMF
Tramadol Hydrochloride
Analgesic
22204-88-2 PhEur CEP, US-DMF, ASMF

Customer Specific Finishing and Regulatory Amendments

For all APIs the Particle Size Distribution can be designed in-house.

Filing for additional regulatory documents upon request is possible.

To the best of our knowledge our narcotic and regular APIs are not protected by patent rights in Germanyl. Patents or supplementary protection certificates, however, may still be valid in some countries. Prior to exporting of our APIs listed, the patent situation will have to be clarified. Products will not be offered for sale to countries where they are covered by valid patents!

The manufacturing of many Arevipharma products is GMP certified, ANVISA, FDA, KFDA and PMDA (paper) inspected and approved.

Vertrieb

Kerstin Dreissig

Tel.: +49 (0)351 8314-1120
E-Mail: kerstin.dreissig@arevipharma.com

Vertrieb

Claudia Böttcher

Tel.: +49 (0)351 8314-1238
E-Mail: claudia.boettcher@arevipharma.com

Vertrieb

Peggy Dutschke

Tel.: +49 (0)351 8314-1147
E-Mail: peggy.dutschke@arevipharma.com

Arevipharma GmbH
Meißner Straße 35
D-01445 Radebeul
Web: www.arevipharma.com
Telefon: +49 (0)351 8314-0
Telefax: +49 (0)351 8314-2100
Geschäftsführung
Herr Dr. Hendrik Baumann
Herr Sebastian Breyer
Handelsregister:
Amtsgericht Dresden, HRB 23835
USt-IdNr.: DE 240935001
Contact
Imprint
AGB
Privacy Statement
Copyright © 2017 • Arevipharma GmbH Generiert: 10 ms